REDANA Trademark

Trademark Overview

On Friday, March 1, 2013, a trademark application was filed for REDANA with the United States Patent and Trademark Office. The USPTO has given the REDANA trademark a serial number of 85863991. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2016. This trademark is owned by Glaxo Group Limited. The REDANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
redana

General Information

Serial Number85863991
Word MarkREDANA
Filing DateFriday, March 1, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 7, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 10, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, February 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2016EXTENSION 5 GRANTED
Thursday, February 11, 2016EXTENSION 5 FILED
Thursday, February 11, 2016TEAS EXTENSION RECEIVED
Thursday, August 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2015EXTENSION 4 GRANTED
Wednesday, July 29, 2015EXTENSION 4 FILED
Wednesday, July 29, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 16, 2015EXTENSION 3 GRANTED
Monday, March 2, 2015EXTENSION 3 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Wednesday, September 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 2, 2014EXTENSION 2 GRANTED
Thursday, August 28, 2014EXTENSION 2 FILED
Thursday, August 28, 2014TEAS EXTENSION RECEIVED
Thursday, March 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 12, 2014EXTENSION 1 GRANTED
Monday, February 17, 2014EXTENSION 1 FILED
Wednesday, March 12, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2014TEAS EXTENSION RECEIVED
Tuesday, September 3, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2013PUBLISHED FOR OPPOSITION
Monday, July 1, 2013TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, June 19, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 3, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 3, 2013ASSIGNED TO EXAMINER
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 5, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

redana pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological